Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial

Richard S Bourne, Gary H Mills, Cosetta Minelli, Richard S Bourne, Gary H Mills, Cosetta Minelli

Abstract

Introduction: Sleep disturbances are common in critically ill patients and when sleep does occur it traverses the day-night periods. The reduction in plasma melatonin levels and loss of circadian rhythm observed in critically ill patients receiving mechanical ventilation may contribute to this irregular sleep-wake pattern. We sought to evaluate the effect of exogenous melatonin on nocturnal sleep quantity in these patients and, furthermore, to describe the kinetics of melatonin after oral administration in this patient population, thereby guiding future dosing schedules.

Methods: We conducted a randomised double-blind placebo-controlled trial in 24 patients who had undergone a tracheostomy to aid weaning from mechanical ventilation. Oral melatonin 10 mg or placebo was administered at 9 p.m. for four nights. Nocturnal sleep was monitored using the bispectral index (BIS) and was expressed in terms of sleep efficiency index (SEI) and area under the curve (AUC). Secondary endpoints were SEI measured by actigraphy and nurse and patient assessments. Plasma melatonin concentrations were measured in nine patients in the melatonin group on the first night.

Results: Nocturnal sleep time was 2.5 hours in the placebo group (mean SEI = 0.26, 95% confidence interval [CI] 0.17 to 0.36). Melatonin use was associated with a 1-hour increase in nocturnal sleep (SEI difference = 0.12, 95% CI -0.02 to 0.27; P = 0.09) and a decrease in BIS AUC indicating 'better' sleep (AUC difference = -54.23, 95% CI -104.47 to -3.98; P = 0.04). Results from the additional sleep measurement methods were inconclusive. Melatonin appeared to be rapidly absorbed from the oral solution, producing higher plasma concentrations relative to similar doses reported in healthy individuals. Plasma concentrations declined biexponentially, but morning (8 a.m.) plasma levels remained supraphysiological.

Conclusion: In our patients, nocturnal sleep quantity was severely compromised and melatonin use was associated with increased nocturnal sleep efficiency. Although these promising findings need to be confirmed by a larger randomised clinical trial, they do suggest a possible future role for melatonin in the routine care of critically ill patients. Our pharmacokinetic analysis suggests that the 10-mg dose used in this study is too high in these patients and may lead to carryover of effects into the next morning. Reduced doses of 1 to 2 mg could be used in future studies.

Trial registration: Current Controlled Trials ISRCTN47578325.

Figures

Figure 1
Figure 1
Flowchart of the study, from patient recruitment to analysis.
Figure 2
Figure 2
Semi-logarithmic plot of mean melatonin plasma concentration (± standard deviation [± SD]) versus clock time after a 10-mg oral solution dose administered at 9 p.m. in critical care patients. *4 a.m. data point. Mean concentration value minus SD is a negative number and cannot be represented on a logarithmic scale.

References

    1. American Academy of Sleep Medicine . The International Classification of Sleep Disorders: Diagnostic & Coding Manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
    1. Cooper AB, Thornley KS, Young GB, Slutsky AS, Stewart TE, Hanly PJ. Sleep in critically ill patients requiring mechanical ventilation. Chest. 2000;117:809–818. doi: 10.1378/chest.117.3.809.
    1. Parthasarathy S, Tobin Martin J. Sleep in the intensive care unit. Intensive Care Med. 2004;30:197–206. doi: 10.1007/s00134-003-2030-6.
    1. Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL, Davis SM, Morrison RS. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001;29:277–282. doi: 10.1097/00003246-200102000-00010.
    1. Cajochen C, Kräuchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol. 2003;15:432–437. doi: 10.1046/j.1365-2826.2003.00989.x.
    1. Kuhlwein E, Hauger RL, Irwin MR. Abnormal nocturnal melatonin secretion and disordered sleep in abstinent alcoholics. Biol Psychiatry. 2003;54:1437–1443. doi: 10.1016/S0006-3223(03)00005-2.
    1. Scheer FA, Zeitzer JM, Ayas NT, Brown R, Czeisler CA, Shea SA. Reduced sleep efficiency in cervical spinal cord injury; association with abolished night time melatonin secretion. Spinal Cord. 2006;44:78–81. doi: 10.1038/sj.sc.3101784.
    1. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Balaum H, Shenkman L. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci. 1999;317:278–281. doi: 10.1097/00000441-199905000-00002.
    1. Frisk U, Olsson J, Nylen P, Hahn RG. Low melatonin excretion during mechanical ventilation in the intensive care unit. Clin Sci. 2004;107:47–53. doi: 10.1042/CS20030374.
    1. Olofsson K, Alling C, Lundberg D, Malmros C. Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand. 2004;48:679–684. doi: 10.1111/j.0001-5172.2004.00401.x.
    1. Ibrahim MG, Bellomo R, Hart GK, Norman TR, Goldsmith D, Bates S, Egi M. A double-blind placebo-controlled randomised pilot study of nocturnal melatonin in tracheostomised patients. Crit Care Resusc. 2006;8:187–191.
    1. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Medicine Rev. 2005;9:25–39. doi: 10.1016/j.smrv.2004.05.002.
    1. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27:1325–1329. doi: 10.1097/00003246-199907000-00022.
    1. Bourne RS, McLaughlin JP, Simpson CC. Benefits on patient's sleep patterns can be studied using a stable oral liquid melatonin formulation. Pharmacy in Practice. 2005;15:246–249.
    1. Bourne RS, Mills GH. Sleep disruption in critically ill patients – pharmacological considerations. Anaesthesia. 2004;59:374–384. doi: 10.1111/j.1365-2044.2004.03664.x.
    1. Bourne RS, Mills GH. Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med. 2006;32:371–379. doi: 10.1007/s00134-005-0061-x.
    1. Nicholson T, Patel J, Sleigh JW. Sleep patterns in intensive care unit patients: a study using the bispectral index. Crit Care Resusc. 2001;3:86–91.
    1. Tung A, Lynch JP, Roizen MF. Use of the BIS monitor to detect onset of naturally occurring sleep. J Clin Monit Comput. 2002;17:37–42. doi: 10.1023/A:1015404803637.
    1. Arendt J, Borbely AA, Franey C, Wright J. The effects of chronic, small doses of melatonin given in the late afternoon on fatigue in man: a preliminary study. Neurosci Lett. 1984;45:317–321. doi: 10.1016/0304-3940(84)90245-3.
    1. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study. Biol Psychiatry. 1991;30:371–376. doi: 10.1016/0006-3223(91)90293-U.
    1. Bourne RS, Minelli C, Mills GH, Kandler R. Sleep measurement in critical care patients: research and clinical implications. Crit Care. 2007;11:226. doi: 10.1186/cc5966.
    1. Richards KC, Bairnsfather L. A description of night sleep patterns in the critical care unit. Heart Lung. 1988;17:35–42.
    1. Richards KC. Effect of a back massage and relaxation intervention on sleep in critically ill patients. Am J Crit Care. 1998;7:288–299.
    1. Richards KC, O'Sullivan PS, Phillips RL. Measurement of sleep in critically ill patients. J Nurs Meas. 2000;8:131–144.
    1. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27:1255–1273.
    1. Harrell RG, Othmer E. Postcardiotomy confusion and sleep loss. J Clin Psychiatry. 1987;48:445–446.
    1. Bosma K, Ferreyra G, Ambrogio C, Pasero D, Mirabella L, Braghiroli A, Appendini L, Mascia L, Ranieri VM. Patient-ventilator interaction and sleep in mechanically ventilated patients: pressure support versus proportional assist ventilation. Crit Care Med. 2007;35:1048–1054. doi: 10.1097/01.CCM.0000260055.64235.7C.
    1. Harrell FE, Jr, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3:143–152. doi: 10.1002/sim.4780030207.
    1. Hardin KA, Seyal M, Stewart T, Bonekat HW. Sleep in critically ill chemically paralyzed patients requiring mechanical ventilation. Chest. 2006;129:1468–1477. doi: 10.1378/chest.129.6.1468.
    1. Nieuwenhuijs DJF. Processed EEG in natural sleep. Baillieres Best Pract Res Clin Anaesthesiol. 2006;20:49–56. doi: 10.1016/j.bpa.2005.08.006.
    1. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Shenkman L. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int. 2000;17:71–76. doi: 10.1081/CBI-100101033.
    1. Fontaine DK. Measurement of nocturnal sleep patterns in trauma patients. Heart Lung. 1989;18:402–410.
    1. Aurell J, Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J. 1985;290:1029–1032.
    1. Tonner P, Paris A, Scholz J. Monitoring consciousness in intensive care medicine. Baillieres Best Pract Res Clin Anaesthesiol. 2006;20:191–200. doi: 10.1016/j.bpa.2005.08.011.
    1. Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Br Med J. 2006;332:385–393. doi: 10.1136/bmj.38731.532766.F6.
    1. Dollins A, Zhdanova I, Wurtman R, Lynch H, Deng M. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA. 1994;91:1824–1828. doi: 10.1073/pnas.91.5.1824.
    1. Hartter S, Nordmark A, Rose DM, Bertilsson L, Tybring G, Laine K. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br J Clin Pharmacol. 2003;56:679–682. doi: 10.1046/j.1365-2125.2003.01933.x.
    1. DeMuro RL, Nafziger AN, Blask DE, Menhinick AM, Bertino JS., Jr The absolute bioavailability of oral melatonin. J Clin Pharmacol. 2000;40:781–784. doi: 10.1177/00912700022009422.
    1. Hartter S, Grozinger M, Weigmann H, Roschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67:1–6. doi: 10.1067/mcp.2000.104071.
    1. Cheng P, Morgan E. Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab. 2001;2:165–183. doi: 10.2174/1389200013338676.
    1. Renton K. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab. 2004;5:235–243. doi: 10.2174/1389200043335559.
    1. Iguchi H, Kato KI, Ibayashi H. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab. 1982;54:1025–1027.
    1. Zhdanova IV. Melatonin as a hypnotic: Pro. Sleep Medicine Rev. 2005;9:51–65. doi: 10.1016/j.smrv.2004.04.003.
    1. Wyatt JK, Dijk DJ, Ritz-de Cecco A, Ronda JM, Czeisler CA. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep. 2006;29:609–618.
    1. Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther. 1995;57:552–558. doi: 10.1016/0009-9236(95)90040-3.
    1. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J. 2005;331:1169–1175. doi: 10.1136/bmj.38623.768588.47.
    1. Gabor JY, Cooper AB, Crombach SA, Lee B, Kadikar N, Bettger HE, Hanly PJ. Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. Am J Respir Crit Care Med. 2003;167:708–715. doi: 10.1164/rccm.2201090.
    1. Pandi-Perumal S, Smits M, Spence W, Srinivasan V, Cardinali D, Lowe A, Kayumov L. Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1–11. doi: 10.1016/j.pnpbp.2006.06.020.
    1. Wallace CJ, Robins J, Alvord LS, Walker JM. The effect of earplugs on sleep measures during exposure to simulated intensive care unit noise. Am J Crit Care. 1999;8:210–219.
    1. Arendt J. Melatonin and human rhythms. Chronobiol Int. 2006;23:21–37. doi: 10.1080/07420520500464361.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe